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ABSTRACT 
PURPOSE: To evaluate the nutritional status of patients in the late postoperative period of pancreaticoduodenectomy (PD) and compare 
the long-term outcome according to pylorus-preserving (PPPD) or the standard technique (SPD) in which the pylorus is resected. 
METHODS: This prospective study was conducted twelve months prior or more in patients who had underwent PD (PD Group, 
n=15) and health volunteers (Control Group, n=15). At a post hoc analysis, the PD Group was divided in PPPD Subgroup (n=9) and 
SPD Subgroup (n=6), according to the PD techniques. Gastrointestinal complaints and nutritional status were evaluated, apart from a 
biochemical assessment; Student t-test or Mann-Whitney test were used. 
RESULTS: The patients recovered their body weight and the gastrointestinal complaints were uncommon. The PD Group showed 
higher energy and protein intake even though BMI was lower than in Control Group. There were no differences in laboratorial data, 
except for higher glycemia, serum alkaline phosfatase and C-reactive protein in PD Group. There was no difference in the various 
parameters evaluated when the Subgroups (PPPD and SPD) were compared. 
CONCLUSION: For long-term pancreaticoduodenectomy, the gastrointestinal symptoms are minimal and the patients had the clinical 
and nutritional status preserved, regardless of pylorus preservation.
Key words: Pancreaticoduodenectomy. Nutritional Status. Anthropometry. Blood Proteins.    
RESUMO
OBJETIVO: Avaliar o estado nutricional de pacientes em pós-operatório tardio de pancreaticoduodenectomia (PD) e comparar a 
evolução de acordo com a preservação de piloro (PPPD) ou pela técnica padrão com ressecção do piloro (SPD). 
MÉTODOS: O estudo prospectivo foi conduzido com pacientes submetidos à PD após período mínimo de 12 meses (Grupo PD, n=15) 
e voluntários saudáveis (Grupo Controle, n=15). Numa análise posterior, o Grupo PD foi dividido em Subgrupo PPPD (n=9) e Subgrupo 
SPD (n=6), de acordo com a técnica de PD. Foram avaliadas as queixas digestivas, o estado nutricional e dados bioquímicos; a análise 
estatística foi realizada por meio do teste t-Student ou Mann-Whitney. 
RESULTADOS: Os pacientes recuperaram o estado nutricional e as queixas gastrointestinais foram incomuns. A ingestão protéica 
e energética foi maior no Grupo PD, apesar do menor IMC. Não houve diferenças em relação aos exames laboratoriais, exceto pelos 
maiores níveis de glicemia, fosfatase alcalina sérica e proteína C-reativa no Grupo PD. Quando os Subgrupos PPPD e SPD foram 
comparados, não houve diferenças nos diversos parâmetros analisados.
CONCLUSÃO: No pós-operatório tardio de pancreaticoduodenectomia, os sintomas gastrointestinais são mínimos e o estado clínico e 
nutricional é adequado, independente da preservação do piloro.
Descritores: Pancreaticoduodenectomia. Estado Nutricional. Antropometria. Proteínas Sanguíneas. 
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Introduction
Pancreaticoduodenectomy (PD) has been performed 
in the treatment of a considerable number of malignant diseases 
such as pancreas, duodenum, ampullary and distal bile duct cancer 
and some benign diseases1-2. In recent decades, several studies 
have been conducted to evaluate clinical and nutritional long-
term effects after PD3-8. However, most studies have not made a 
complete nutritional assessment and they do not describe digestive 
complaints or details of food intake patterns. Moreover, the PD 
techniques haven’t been standardized or described in detail, which 
may compromise the critical analysis of the results. 
Among the surgical factors that may influence the 
clinical outcomes, the International Study Group of Pancreatic 
Surgery reported the pancreatoenteric anastomosis such as the 
use of  pancreatojejunostomy and pancreatogastrostomy, duct-to-
mucosa anastomosis, invagination (dunking) of the remnant into 
the jejunum or stomach, and the use of a stent (internal or external) 
across the anastomosis9. In the standard pancreaticoduodenectomy 
(SPD, or classical Whipple’s procedure), the head of the pancreas, 
duodenum, common bile duct, gallbladder, and distal stomach, 
including the pylorus are resected and the gastrointestinal tract 
is restored by gastrojejunostomy. The pancreaticoduodenectomy 
pylorus-preserving PD (PPPD) is similar to SPD, except that the 
antrum and pylorus are left intact, and the gastrointestinal tract is 
restored by duodenojejunostomy10.
Perform studies have been recommended, which avoid 
potentially biasing variables and which clarify the impact of surgical 
techniques on the clinical and nutritional status years after surgery9. 
These data would allow the establishment of guidelines in order to 
improve the life quality of pancreas, ampullary and periampullary 
cancer survivors. The purpose of this study was to evaluate the 
nutritional status of patients in the late postoperative period of 
pancreaticoduodenectomy, apart from comparing the outcome 
according with pylorus-preserving pancreaticoduodenectomy 
(PPPD) and standard pancreaticoduodenectomy (SPD) techniques.
Methods 
This study was conducted in a public university hospital 
after approval by the institutional Ethics Committee and all subjects 
signed an informed consent. A list containing 71 names of patients 
who underwent PD between 2000 and 2010 was obtained. Twenty-
five patients were deceased and 17 individuals had inconsistent 
registration data and/or impossibility of contact by telephone. Eight 
patients were excluded because they were less than one year from 
surgery and they received postoperative adjuvant chemotherapy. 
Four individuals were undergoing chemotherapy due to residual 
or recurrent neoplastic disease and two subjects refused to 
participate. No patient showed increased serum levels of CA19-
9 or evidence of thoracic and abdominal mass at computerized 
tomography. Upper gastrointestinal endoscopy was done by the 
same endoscopist and no patient presented obstructions in the 
pancreaticojejunal and hepaticojejunal anastomoses. 
The final casuistic included patients who underwent PD 
(PD Group, n=15) twelve months prior to evaluation or more, 12 
men and 3 women, 60.4 ± 13.2 years. At a post hoc analysis, the PD 
Group was divided in PPPD Subgroup (n=9) and SPD Subgroup 
(n=6), according to the PD techniques. The individual description 
of the surgical procedure, the histopathological diagnosis and 
the TNM classification were obtained by medical record review 
(Table 1). The study also included health volunteers (Control 
Group, n=15), 11 men and 4 women, 58.1 ± 12.6 years, paired by 
socioeconomic levels. 
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TABLE 1 - Demographic characteristics of patients who underwent PD surgery, time elapsed after surgery, histopathological 
diagnosis and TNM classification.
Case
Type of PD 
surgery
Gender
Age
(years)
Time elapsed after 
surgery (months)
Histopathological diagnosis TNM classification
1 SPD Male 61 120 Carcinoma of papilla of Vater pT2N0M0
2 SPD Female 63 120 Carcinoma of papilla of Vater pT2N0M0
3 SPD Male 79 119 Carcinoma of papilla of Vater pT3N0Mx
4 SPD Male 79 108 Carcinoma of papilla of Vater pT1N1M0
5 SPD Male 57 65 Carcinoma of papilla of Vater pT1N1Mx
6 SPD Male 63 12 Carcinoma of papilla of Vater pT3N0M1
7 PPPD Male 60 52 Neuroendocrine tumor Not applicable
8 PPPD Male 61 46 Carcinoma of papilla of Vater pT3N1M0
9 PPPD Male 53 45 Distal bile duct carcinoma pT3N0M0
10 PPPD Male 67 31 Carcinoma of papilla of Vater pT3N1Mx 
11 PPPD Male 69 30 Pancreatic head carcinoma pT3N0Mx 
12 PPPD Female 64 29 Carcinoma of papilla of Vater pT2N1M0
13 PPPD Male 58 20 Carcinoma of papilla of Vater pT2N0M0
14 PPPD Female 24 13 Frantz’ tumor Not applicable
15 PPPD Male 50 12 Desmoid tumor Not applicable
Surgical procedures
All PD patients were assessed at least 12 months 
after surgery. This postoperative period was chosen to exclude 
the possibility that the assessment of clinical and nutritional 
parameters could have been influenced by inflammatory stress 
due to surgery or concurrent illness. All patients were operated 
on by a single team, using the standard techniques. Except for 
the presence (PPPD Subgroup) or absence of antrum and pylorus 
(SPD Subgroup), the same procedures were performed in all 
patients, which included: (a) single-loop pancreatic and biliary 
reconstruction; (b) pancreatojejunostomy; (c) duct-to-mucosa 
anastomosis; (d) internal pancreatic duct silicone stent (6 to 10 Fr, 
around 10 cm) and (e) interrupted suturing with polyprolpylene 
5-0 suture. 
Gastrointestinal complaints and nutritional status
All patients were interviewed regarding their 
gastrointestinal symptoms, like anorexia, abdominal pain, early 
satiety, diarrhea, steatorrhea and dumping. All volunteers were 
assessed by a registered dietitian. The analysis of the composition 
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of the habitual diet was based upon the Semi-Quantitative Food 
Frequency Questionnaire, using a book containing pictures of 
food portions in different sizes as well as of cooking utensils. 
The nutrient intake was computed over the preceding six-month 
period, by means of specific software (NutWin Profissional® 1.5 
– Software, UNIFESP, Sao Paulo, Brazil). The energy and protein 
intake were expressed by body weight and vitamins and minerals 
were compared with the specific recommendations. 
Anthropometric measurements were done using standard 
techniques and included weight, height, body mass index (BMI, 
weight/height2). The Subjective Global Assessment (SGA) ranked 
patients into three groups: well-nourished, moderately or suspected 
of being malnourished, and severely malnourished11. 
Laboratorial assessment 
Visceral protein mass was determined by measuring 
the total protein, albumin and transferrin serum concentrations. 
Immune competence was indirectly assessed by measuring the total 
lymphocyte counts. Other laboratory tests included hemoglobin, 
mean corpuscular volume, serum mineral and electrolytes, fasting 
glucose, liver enzymes, uric acid and plasmatic lipids. C-reactive 
protein was measured to act as a screen for inflammatory stress. 
Statistical analysis
Data analyses were performed with the Statistica® 
software (version 7.0, StatSoft Inc, Tulsa, Oklahoma, USA). 
Variables with normal distribution were analyzed by Student t-test 
and reported as mean ± SDs. Those with non-normal distribution 
were analyzed by Mann-Whitney test and reported as median 
values and range. Statistical significance was set at p < 0.05.
Results
Gastrointestinal complaints and nutritional status
No PD patient complained at anorexia or early satiety. A 
slight reduction in the amount of food ingested in the last 2 weeks 
was reported by two patients, and it was attributed to injuries in 
the oral cavity. Mild abdominal pain, eructation and postprandial 
epigastric fullness were cited by three patients, independent of 
the preservation of the antrum and pylorus. In PPPD Subgroup, 
one patient used oral anti-diabetic drugs and pancreatic enzyme 
supplements regularly due to endocrine and exocrine pancreatic 
insufficiency. Only one patient used insulin regularly, but he 
had diabetes mellitus diagnosed before the PD. Dumping was 
diagnosed in one patient in PPPD Subgroup, who also exhibited 
exocrine pancreatic insufficiency and used enzyme therapy. 
Compared to Control Group, the PD Group had a higher 
energy (41.7 ± 9.4 vs. 29.3 ± 9.7 kcal/kg, p=0.001) and protein 
intake (1.6 ± 0.5 vs. 1.1 ± 0.3 g/kg, p=0.01). The vitamins and 
minerals were similar between the groups and in accordance with 
the recommendations. There were not significant differences in 
the energy (39.1 ± 8.5 vs. 45.7 ± 10.1 kcal/kg, p=0.19) and protein 
(1.6 ± 0.5 vs. 1.5 ± 0.6 g/kg, p=0.57) between PPPD and SPD 
Subgroups when the dietary intake data were compared.
Although PD patients had presented a weight loss of 20.1 
(7.1-35.4) kg following surgery, at the time of evaluation they had 
recovered 90.8 ± 10.7% of their lost weight. In the last 6 months, 
only two patients had lost body weight (< 10%) and nobody 
complained at diminished functional capacity. At evaluation, the 
BMI was lower in PD Group than in Control Group (24.5 ± 3.9 
vs. 27.4 ± 3.5 kg/m2, p=0.004). However, the BMI (25.4 ± 4.4 vs. 
23.2 ± 2.9 kg/m2, p=0.32) was similar between PPPD and SPD 
Subgroups. Based on SGA, only one patient (PPPD Subgroup) 
was moderately or suspected of being malnourished, the others 
were considered as well nourished. 
Laboratorial assessment 
Laboratory data regarding clinical and nutritional status 
of PD and Control Groups (Table 2) show no differences, except 
for higher values of glycemia, alkaline phosphatase and C-reactive 
protein in the PD Group. Fasting glucose higher than 110 mg/dL 
was documented in 4 patients of PPPD Subgroup and 1 patient of 
SPD Subgroup. 
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TABLE 2 - Clinical and nutritional laboratory data in the PD and Control Groups.
PD Group
 (n=15)
Control Group
 (n=15)
p value Normal range
Total protein (g/dL) 7.1 ± 0.6 6.7 ± 0.2 0.03 6.0-8.5 
Albumin (g/dL) 4.2 ± 0.9 4.3 ± 0.2 0.29 3.5-4.8 
Transferrin (mg/dL) 220 ± 51 204 ± 29 0.29 < 170 
Hemoglobin (g/dL) 14.2 ± 1.5 14.8 ± 1.5 0.29 13.5-17.5
Mean corpuscular volume (fL) 92 ± 4 91 ± 5 0.78 81-95 
Total lymphocytes (cells/mm3) 1873 ± 771 1886 ± 497 0.95 900-2900
Iron (mg/dL) 94 ± 27 104 ± 33 0.41 40-160 
Copper (μg/dL) 105 ± 30 94 ± 17 0.25 70-140 
Sodium (Mmol/L) 139 ± 2 140 ± 3 0.22 135-145 
Potassium (Mmol/L) 4.4 ± 0.4 4.3 ± 0.4 0.56 3.5-5.0 
Glycemia (mg/dL) 107 ± 29 87 ± 15 0.03 70-100 
Creatinine (mg/dL) 1.0 ± 0.2 1.0 ± 0.2 0.97 0.7-1.5 
Total bilirrubin (mg/dL) 0.7 ± 0.4 0.7 ± 0.2 0.93 0.2-1.2 
Alkaline phosfatase (U/L) 295 ± 150 172 ± 34 0.004 65-300
Alanine aminotransferase (U/L) 18 (10-298) 23 (12- 88) 0.36 < 38 
Aspartate aminotransferase (U/L) 27 (14-173) 24 (19-44) 0.62 < 41 
γ-Glutamyl transferase (mg/dL) 33 (21-211) 35 (19-216) 0.90 11-50 
Uric acid (mg/dL) 4.7 ± 1.2 5.5 ± 1.8 0.17 2.5-6.0 
Total cholesterol (mg/dL) 170 ± 42 197 ± 34 0.07 < 200 
LDL–cholesterol (mg/dL) 107 ± 30 120 ± 28 0.26 < 130 
HDL–cholesterol (mg/dL) 41 ± 9 48 ± 11 0.06 > 35
Triglycerides (mg/dL) 110 ± 48 147 ± 93 0.19 < 150 
C-reactive protein (mg/dL) 0.26 (0.06-2.61) 0.15 (0.01-0.72) 0.01 < 0.5 
In the PD Group, there was no statistical difference when 
the laboratorial parameters were compared according to PPPD and 
SPD techniques (Table 3). The visceral proteins were within the 
normal limits for all patients, except in one case following SPD, 
which presented total protein and albumin at normality’s lower 
limit. 
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TABLE 3 - Clinical and nutritional laboratory data in the PPPD and SPD SubGroups.
PPPD Subgroup
 (n=9)
SPD Subgroup
(n=6)
p value
Total protein (g/dL) 7.2 ± 0.6 6.9 ± 0.7 0.45
Albumin (g/dL) 4.3 ± 0.4 4.0 ± 0.3 0.22
Transferrin (mg/dL) 224 ± 57 215 ± 47 0.76
Hemoglobin (g/dL) 14.6 ± 1.8 13.6 ± 0.8 0.21
Mean corpuscular volume (fL) 91 ± 5 93 ± 4 0.40
Total lymphocytes (cells/mm3) 2056 ± 572 1600 ± 547 0.28
Iron (mg/dL) 102 ± 32 83 ± 15 0.21
Copper (μg/dL) 108 ± 33 100 ± 25 0.65
Sodium (Mmol/L) 139 ± 2 138 ± 2 0.65
Potassium (Mmol/L) 4.3 ± 0.4 4.5 ± 0.5 0.44
Glycemia (mg/dL) 114 ± 35 96 ± 12 0.26
Creatinine (mg/dL) 0.9 ± 0.1 1.1 ± 0.3 0.40
Total bilirrubin (mg/dL) 0.8 ± 0.5 0.6 ± 0.3 0.27
Alkaline phosfatase (U/L) 334 ± 172 236 ±94 0.23
Alanine aminotransferase (U/L) 20 (14-298) 17 (10-40) 0.89
Aspartate aminotransferase (U/L) 27 (14-173) 25 (19-40) 1.00
γ-Glutamyl transferase (mg/dL) 37 (24-184) 30 (21-211) 0.22
Uric acid (mg/dL) 4.6 ± 1.4 4.9 ± 0.9 0.60
Total cholesterol (mg/dL) 170 ± 31 170 ± 61 0.99
LDL–cholesterol (mg/dL) 108 ± 23 106 ± 44 0.88
HDL–cholesterol (mg/dL) 39 ± 5 44 ± 13 0.29
Triglycerides (mg/dL) 114 ± 37 102 ± 68 0.65
C-reactive protein (mg/dL) 0.23 (0.06-2.61) 0.3 (0.13-0.76) 0.68
Discussion
This study shows that digestive complaints were mild 
and body weight was within normal limits in patients undergoing 
PD. The patients had higher blood glucose, alkaline phosphatase 
and C-reactive protein when compared to Control Group. There 
were no differences in the various parameters evaluated when the 
patients submitted to PD were analyzed according to whether or 
not the preservation of the antrum and pylorus was performed.
In the late postoperative period, the appetite and dietary 
intake are limited by gastrointestinal symptoms like nausea, 
flatulence, epigastric fullness, vomiting, and diarrhea8. In this study, 
the gastrointestinal symptoms were scarce and seemed not to have 
interfered with the usual food intake. Only two patients (13.3%) 
showed steatorrhea and needed pancreatic enzymes, while this 
condition varied from 18 to 73% in several studies4,5,8,12,13. In our 
casuistic, the lower number of patients with pancreatic exocrine 
insufficiency can be attributed to the efficiency of duct-to-mucosa 
pancreatojejunal anastomosis. Some researches showed that the 
pancreatic exocrine insufficiency was less frequent when pancreas 
anastomosis was performed in the jejunum (pancreatojejunostomy) 
than in the stomach (pancreatogastrostomy)14,15. 
In our series, the energy and protein intake were higher 
in the PD Group than in the Control Group. Some studies have 
reported that the PD patients had adequate energy intake16 
and similar to patients who underwent subtotal gastrectomy12, 
cholecystectomy13 or healthy controls17. Our results can be 
attributed to good adherence to dietary guidelines but it is possible 
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that the food intake was over-reported due to limitations inherent 
to food questionnaires methodologies18. 
In the present study, PD patients had a recovery of 
around 90% of the previous body weight and they presented 
weight within the normal range.  Early studies showed that 
5019 to 25%20 of patients undergoing PD have not recovered the 
body weight postoperatively. Our results are similar to studies 
conducted during the 90’s which showed a recovery of 85 to 95% 
of the lost weight after at least 4 months of PD6,12 and adequacy of 
anthropometric data4,6,17. The weight restoring is determined by the 
food intake pattern, pancreatic insufficiency extent and the raise 
in energy expenditure.  The only patient who was considered as 
malnourished by the SGA or anthropometric data had exocrine 
pancreatic insufficiency. The difference in the BMI values between 
the PD and Control Groups can be attributed to the fact that 
some subjects in the Control Group were overweight. However, 
considering the prevalence of hyperglycemia in our patients, it is 
possible that endocrine pancreatic failure justifies the lower body 
weight in PD Group. 
Similarly to our results, some authors did not point 
any differences between the SPD and PPPD patients’ weight4,5. 
However, the pylorus preservation seems to have advantages in 
the functional and nutritional status3,8. A longitudinal follow-up 
showed that differences in postoperative weight gain are correlated 
rather with resection margins and tumor recurrence than with the 
type of resection5. 
Our patients showed no changes in protein metabolism 
markers and serum minerals. A low level of hemoglobin was not a 
common problem, although mild or severe anemia was documented 
in 28% of the patients who underwent PD4. Similar to our results, 
some studies showed normal transferrin levels in all patients4,12,21 
and they observed no differences in the albumin levels between 
SPD and PPPD patients4,5,21. On the other hand, in a large group 
of cases which were evaluated at least 6 months postoperatively, 
higher serum albumin was demonstrated in patients undergoing 
PPPD as compared to SPD3.
In the present study both AST and ALT were at normal 
levels and no subject used hepatotoxic drugs. The increase 
in alkaline phosphatase suggests subclinical hepatobiliary 
involvement, even though cholangitis was not observed and 
endoscopy showed the anastomoses were wide and unobstructed. 
Contact between enteric content and the bile duct is a common 
occurrence after biliodigestive anastomosis and endoscopic biliary 
drainage22. After biliodigestive anastomosis, transitory episodes of 
cholestasis and cholangitis have been documented in experimental 
models23,24 and in humans25. It is possible that enteric contents 
stagnated in the excluded loop and in the biliary duct anastomosis 
could explain the increased alkaline phosphatase. The increased 
levels of C-reactive protein in PD Group may be part of liver 
dysfunction, as occur in other clinical situations26. 
Among the strengths of this study we may point out the 
standardization of surgical techniques, including pancreaticojejunal 
anastomosis9, the strict inclusion criteria, and the simultaneous 
use of distinct techniques to assess the nutritional status. The 
limitation of this study was the small sample size, justified by 
the low survival rate of patients who underwent PD. In patients 
with unsatisfactory postoperative clinical and nutritional status, an 
exclusion of recurrent tumor activity and assessment of pancreatic 
exocrine function are mandatory. In addition, pancreatic endocrine 
function should be continuously monitored, especially when body 
weight is not adequate. Finally, small increases in liver enzymes 
should be measured and continuously monitored. 
Conclusion
For long-term pancreaticoduodenectomy, the 
gastrointestinal symptoms are minimal and the patients had the 
clinical and nutritional status preserved, regardless of pylorus 
preservation.
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